Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.

Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis. — المؤلف: George, Daniel J — Clinical cancer research : an official journal of the American Association for Cancer Research 20200420

المؤلف
George, Daniel J
النشر
Clinical cancer research : an official journal of the American Association for Cancer Research 20200420
الوصف
1165-1173 p.
الموضوعات
Aged؛ Carcinoma, Renal Cell؛ Chemotherapy, Adjuvant؛ Disease-Free Survival؛ Female؛ Humans؛ Male؛ Middle Aged